Department of Technology and Biotechnology of Drugs, Jagiellonian University Medical College, Kraków, Poland.
Bioorg Med Chem Lett. 2010 Oct 15;20(20):6152-6. doi: 10.1016/j.bmcl.2010.07.101. Epub 2010 Jul 30.
A series of phenylpiperazine derivatives of phenytoin was evaluated for their affinity at α(1)-adrenoceptor subtypes in functional bioassays (rat tail artery: α(1A) and/or α(1B); guinea pig spleen: α(1B); rat aorta: α(1D)). The most potent compounds at α(1A)-, α(1B)- and α(1D)-adrenoceptors, 11, 18 and 8, showed affinities in the submicromolar range. The role of a hydrogen bond donor group for affinity and selectivity at α(1B)-adrenoceptors, postulated by Bremner's pharmacophore model, was confirmed by functional and molecular modelling studies.
一系列苯妥英的苯哌嗪衍生物在功能生物测定中评估了它们在α(1)-肾上腺素受体亚型上的亲和力(大鼠尾动脉:α(1A)和/或α(1B);豚鼠脾脏:α(1B);大鼠主动脉:α(1D))。在α(1A)-、α(1B)-和α(1D)-肾上腺素受体上最有效的化合物 11、18 和 8,显示出亚微摩尔范围内的亲和力。布雷默药效基团模型提出的氢键供体基团对 α(1B)-肾上腺素受体亲和力和选择性的作用,通过功能和分子建模研究得到了证实。